SCHEMBL22209271

SCHEMBL22209271

CC(C)C1CC12CN(C(C)C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14497312 0.83 HRH3 (0.33) —
SCHEMBL24819398 0.83 HRH3 (0.33) —
SCHEMBL23542611 0.78 — —
SCHEMBL19008943 0.77 HRH3 (0.38) —
SCHEMBL22645239 0.76 — —
SCHEMBL19756431 0.75 SMN1; SMN2 (0.31) —
SCHEMBL16984140 0.75 SMN1; SMN2 (0.31) —
SCHEMBL20892854 0.74 — —
SCHEMBL22752326 0.73 SMN1; SMN2 (0.31) —
SCHEMBL21584910 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208981-A1 NITROGEN-CONTAINING HETEROCYCLIC POLYCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2024-06-27 — — US disclosed
US-20200354357-A1 AUTOTAXIN INHIBITORS AND USES THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2020-11-12 — — US disclosed
US-10711000-B2 Autotaxin inhibitors and uses thereof FRONTHERA U.S. PHARMACEUTICALS LLC (US) 2020-07-14 — — US disclosed
Send feedback